Skip to main content

The REPROCELL Blog

Research • Reports • Resources

Latest Posts

Featured Posts

Why mRNA Reprogramming Is the Key to Safer and Faster iPSC Generation?

Why mRNA Reprogramming Is the Key to Safer and Faster iPSC Generation?

Discover how mRNA reprogramming enhances the safety, efficiency, and scalability of iPSC generation for therapeutic applications. Explore REPROCELL's innovative technologies and services.

How human fresh tissue models are helping RCD405 achieve regulatory approval

How human fresh tissue models are helping RCD405 achieve regulatory approval

Discover how Arcede Pharma recently used human tissue testing to generate preclinical efficacy data for their compound RCD405.

How to isolate PBMCs from whole blood using density gradient centrifugation

How to isolate PBMCs from whole blood using density gradient centrifugation

Find out how to isolate PBMCs from whole blood samples using density gradient centrifugation a.k.a. the Ficoll Overlay method.

Streamlining PBMC Processing for Reliable Results in Multi-Site Clinical Trials: Key Challenges and Solutions

Streamlining PBMC Processing for Reliable Results in Multi-Site Clinical Trials: Key Challenges and Solutions

Explore the challenges and solutions in PBMC processing for multi-site clinical trials, ensuring reliable results and data integrity for research success.

AI-Designed CRISPR Enables Hypoimmune iPSC Engineering for Off-the-Shelf Cell Therapy

AI-Designed CRISPR Enables Hypoimmune iPSC Engineering for Off-the-Shelf Cell Therapy

REPROCELL's StemEdit platform enables the creation of hypoimmune iPSCs for scalable off-the-shelf cell therapies, reducing immune rejection and enhancing patient access.

The Resurgence of New Approach Methodologies (NAMs) in Drug Discovery and Safety Assessment

The Resurgence of New Approach Methodologies (NAMs) in Drug Discovery and Safety Assessment

Explore how New Approach Methodologies are revolutionizing drug discovery and safety assessment by enhancing human-relevant research and reducing reliance on animal testing.

30 April 2026

Revolutionizing IBD Research with Innovative In Vitro Models

Revolutionizing IBD Research with Innovative In Vitro Models

Catch a glimpse into the future of inflammatory bowel disease (IBD) research with our ground breaking in vitro models.

11 August 2025

Redefining Success in IBD Drug Discovery with Human Tissue Models

Redefining Success in IBD Drug Discovery with Human Tissue Models

Redefining IBD drug discovery with a dual-pronged approach through human bioengineered and fresh tissue.

11 December 2024

Harnessing Functional Genomics to Revolutionize Inflammatory Bowel Disease Treatment

Harnessing Functional Genomics to Revolutionize Inflammatory Bowel Disease Treatment

Discover how functional genomics is transforming IBD treatment with groundbreaking research on ETS2's role in inflammation.

07 June 2024

The influence of the microbiome on inflammatory bowel disease

The influence of the microbiome on inflammatory bowel disease

Learn about the the influence of the gut microbiome on inflammatory bowel disease (IBD) and how precision medicine may change the way we treat IBD.

18 March 2022

Four reasons human tissues should be used to predict drug bioavailability

Four reasons human tissues should be used to predict drug bioavailability

Find out why human tissues should be used to predict drug bioavailability and permeability on the REPROCELL blog.

29 January 2020

IBDiscovery: Combining patient and drug discovery data to transform healthcare

IBDiscovery: Combining patient and drug discovery data to transform healthcare

Learn how REPROCELL's IBDisocvery project is combining patient and drug discovery data to transform healthcare.

16 September 2019

An Improved Model for IBD Drug Discovery

An Improved Model for IBD Drug Discovery

Looking to find an improved model for IBD drug discovery? Find out the benefits of human tissue testing on the REPROCELL blog.

11 July 2019

Advances in diagnostics, treatments, and frontiers of research in IBD

Advances in diagnostics, treatments, and frontiers of research in IBD

Find out the latest advances in diagnostics, treatments, and frontiers of research in IBD on the REPROCELL blog.

13 June 2019

Subjects we write about

  1. 3D Cell Culture
  2. Cell Culture
  3. Central Lab Services
  4. Clinical Capabilities
  5. Disease Modeling
  6. Drug Discovery
  7. Gene Editing
  8. Genomic Services
  9. GMP
  10. Human Tissue Samples
  11. Human Tissue Testing
  12. IBD
  13. Life Sciences
  14. Master Cell Banks
  15. Neurons
  16. Oligonucleotide Synthesis
  17. Pharmacology-AI
  18. Precision Medicine
  19. Product Catalog
  20. Regenerative Medicine
  21. Respiratory Disease
  22. Safety Pharmacology
  23. Skin Disease
  24. Stem Cells